Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Researchers provide new mask update for prevention of respiratory virus infections in healthcare and community settings

Researchers provide new mask update for prevention of respiratory virus infections in healthcare and community settings

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

COVID-19 Moderna vaccine induces significant antibody reactions among children

COVID-19 Moderna vaccine induces significant antibody reactions among children

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Researchers present a novel genomic sequence data-based mathematical framework for rapid detection of SARS-CoV-2 variants

Researchers present a novel genomic sequence data-based mathematical framework for rapid detection of SARS-CoV-2 variants

The kinetics of SARS-CoV-2 nucleocapsid antibodies up to 21 months after infection

The kinetics of SARS-CoV-2 nucleocapsid antibodies up to 21 months after infection

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Icelandic study reveals how many children experience severe COVID symptoms

Icelandic study reveals how many children experience severe COVID symptoms

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

Highly specialized T cells remain in blood 20 months after COVID-19

Highly specialized T cells remain in blood 20 months after COVID-19

The nose key to winning the war against COVID-19

The nose key to winning the war against COVID-19

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Study shows the emerging Omicron sublineage BA.2.75 does not show greater immune evasion than BA.5

Study shows the emerging Omicron sublineage BA.2.75 does not show greater immune evasion than BA.5

UK study finds over 100 symptoms of long COVID in non-hospitalized adults

UK study finds over 100 symptoms of long COVID in non-hospitalized adults

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Scientists explore post-COVID-19 conditions among children

Scientists explore post-COVID-19 conditions among children

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.